Advertisement

HRS Expert Consensus Statement on remote interrogation and monitoring for cardiovascular implantable electronic devices

      Cardiovascular implantable electronic devices (CIEDs) have evolved significantly since the publication of the 2008 Heart Rhythm Society (HRS) consensus statement
      • Wilkoff B.L.
      • Auricchio A.
      • Brugada J.
      • et al.
      HRS/EHRA Expert Consensus on the Monitoring of Cardiovascular Implantable Electronic Devices (CIEDs): description of techniques, indications, personnel, frequency and ethical considerations: developed in partnership with the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA); and in collaboration with the American College of Cardiology (ACC), the American Heart Association (AHA), the European Society of Cardiology (ESC), the Heart Failure Association of ESC (HFA), and the Heart Failure Society of America (HFSA). Endorsed by the Heart Rhythm Society, the European Heart Rhythm Association (a registered branch of the ESC), the American College of Cardiology, the American Heart Association.
      outlining recommended monitoring strategies. Novel embedded technologies have created the ability of the devices to monitor their own function, record arrhythmias and other physiological parameters, and communicate this information to health care providers without the active participation of the patient. CIEDs with wireless remote monitoring (RM) capabilities stand at the forefront of a new class of medical devices that will unobtrusively acquire vital data beyond the walls of health care facilities and seamlessly transmit the information back to health care providers. This document focuses on implantable devices for managing heart rhythm disorders.

      Abbreviations:

      ABIM (American Board of Internal Medicine), CIED (cardiac implantable electronic device), CRT-D (cardiac resynchronization therapy with defibrillator), IBHRE (International Board of Heart Rhythm Examiners), IPE (in-person evaluationn), RM (remote monitoring)

      Keywords

      To read this article in full you will need to make a payment

      Subscribe:

      Subscribe to Heart Rhythm
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Wilkoff B.L.
        • Auricchio A.
        • Brugada J.
        • et al.
        HRS/EHRA Expert Consensus on the Monitoring of Cardiovascular Implantable Electronic Devices (CIEDs): description of techniques, indications, personnel, frequency and ethical considerations: developed in partnership with the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA); and in collaboration with the American College of Cardiology (ACC), the American Heart Association (AHA), the European Society of Cardiology (ESC), the Heart Failure Association of ESC (HFA), and the Heart Failure Society of America (HFSA). Endorsed by the Heart Rhythm Society, the European Heart Rhythm Association (a registered branch of the ESC), the American College of Cardiology, the American Heart Association.
        Heart Rhythm. 2008; 5: 907-925
        • Al-Khatib S.M.
        • Mi X.
        • Wilkoff B.L.
        • Qualls L.G.
        • Frazier-Mills C.
        • Setoguchi S.
        • Hess P.L.
        • Curtis L.H.
        Follow-up of patients with new cardiovascular implantable electronic devices: are experts’ recommendations implemented in routine clinical practice?.
        Circ Arrhythm Electrophysiol. 2013; 6: 108-116
        • Halimi F.
        • Clementy J.
        • Attuel P.
        • Dessenne X.
        • Amara W.
        OEDIPE Trial Investigators. Optimized post-operative surveillance of permanent pacemakers by home monitoring: the OEDIPE trial.
        Europace. 2008; 10: 1392-1399
        • Dubner S.
        • Auricchio A.
        • Steinberg J.S.
        • et al.
        ISHNE/EHRA expert consensus on remote monitoring of cardiovascular implantable electronic devices (CIEDs).
        Ann Noninvasive Electrocardiol. 2012; 17: 36-56
        • Burri H.
        Remote follow-up and continuous remote monitoring, distinguished.
        Europace. 2013; 15: i14-i16
        • Varma N.
        • Pavri B.B.
        • Stambler B.
        • Michalski J.
        TRUST Investigators. Same-day discovery of implantable cardioverter defibrillator dysfunction in the TRUST remote monitoring trial: influence of contrasting messaging systems.
        Europace. 2013; 15: 697-703
        • Varma N.
        • Stambler B.
        • Chun S.
        Detection of atrial fibrillation by implanted devices with wireless data transmission capability.
        Pacing Clin Electrophysiol. 2005; 28: S133-S136
        • Jacobs A.K.
        • Anderson J.L.
        • Halperin J.L.
        The evolution and future of ACC/AHA clinical practice guidelines: a 30-year journey: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
        J Am Coll Cardiol. 2014; 64: 1373-1384
        • Crossley G.H.
        • Chen J.
        • Choucair W.
        • Cohen T.J.
        • Gohn D.C.
        • Johnson W.B.
        • Kennedy E.E.
        • Mongeon L.R.
        • Serwer G.A.
        • Qiao H.
        • Wilkoff B.L.
        Clinical benefits of remote versus transtelephonic monitoring of implanted pacemakers.
        J Am Coll Cardiol. 2009; 54: 2012-2019
        • Schoenfeld M.H.
        • Compton S.J.
        • Mead R.H.
        • Weiss D.N.
        • Sherfesee L.
        • Englund J.
        • Mongeon L.R.
        Remote monitoring of implantable cardioverter defibrillators: a prospective analysis.
        Pacing Clin Electrophysiol. 2004; 27: 757-763
        • Al-Khatib S.M.
        • Piccini J.P.
        • Knight D.
        • Stewart M.
        • Clapp-Channing N.
        • Sanders G.D.
        Remote monitoring of implantable cardioverter defibrillators versus quarterly device interrogations in clinic: results from a randomized pilot clinical trial.
        J Cardiovasc Electrophysiol. 2010; 21: 545-550
        • Cronin E.M.
        • Ching E.A.
        • Varma N.
        • Martin D.O.
        • Wilkoff B.L.
        • Lindsay B.D.
        Remote monitoring of cardiovascular devices: a time and activity analysis.
        Heart Rhythm. 2012; 9: 1947-1951
        • Theuns D.A.
        • Res J.C.
        • Jordaens L.J.
        Home monitoring in ICD therapy: future perspectives.
        Europace. 2003; 5: 139-142
        • Joseph G.K.
        • Wilkoff B.L.
        • Dresing T.
        • Burkhardt J.
        • Khaykin Y.
        Remote interrogation and monitoring of implantable cardioverter defibrillators.
        J Interv Card Electrophysiol. 2004; 11: 161-166
        • Varma N.
        • Epstein A.E.
        • Irimpen A.
        • Schweikert R.
        • Love C.
        TRUST Investigators. Efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-up: the Lumos-T Safely Reduces Routine Office Device Follow-up (TRUST) trial.
        Circulation. 2010; 122: 325-332
        • Varma N.
        • Michalski J.
        • Stambler B.
        • Pavri B.B.
        TRUST Investigators. Superiority of automatic remote monitoring compared with in-person evaluation for scheduled ICD follow-up in the TRUST trial—testing execution of the recommendations.
        Eur Heart J. 2014; 35: 1345-1352
        • Ricci R.P.
        • Morichelli L.
        • D’Onofrio A.
        • Calò L.
        • Vaccari D.
        • Zanotto G.
        • Curnis A.
        • Buja G.
        • Rovai N.
        • Gargaro A.
        Effectiveness of remote monitoring of CIEDs in detection and treatment of clinical and device-related cardiovascular events in daily practice: the HomeGuide Registry.
        Europace. 2013; 15: 970-977
        • Ricci R.P.
        • Morichelli L.
        • D’Onofrio A.
        • Calo L.
        • Vaccari D.
        • Zanotto G.
        • Curnis A.
        • Buja G.
        • Rovai N.
        • Gargaro A.
        Manpower and outpatient clinic workload for remote monitoring of patients with cardiac implantable electronic devices: data from the HomeGuide Registry.
        J Cardiovasc Electrophysiol. 2014; 25: 1216-1223
        • Hindricks G.
        • Elsner C.
        • Piorkowski C.
        • Taborsky M.
        • Geller J.C.
        • Schumacher B.
        • Bytesnik J.
        • Kottkamp H.
        Quarterly vs. yearly clinical follow-up of remotely monitored recipients of prophylactic implantable cardioverter-defibrillators: results of the REFORM trial.
        Eur Heart J. 2014; 35: 98-105
        • Boriani G.
        • Da Costa A.
        • Ricci R.P.
        • et al.
        The MOnitoring Resynchronization dEvices and CARdiac patiEnts (MORE-CARE) randomized controlled trial: phase 1 results on dynamics of early intervention with remote monitoring.
        J Med Internet Res. 2013; 15: e167
        • Crossley G.
        • Boyle A.
        • Vitense H.
        • Chang Y.
        • Mead R.H.
        The CONNECT (Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision) trial: the value of wireless remote monitoring with automatic clinician alerts.
        J Am Coll Cardiol. 2011; 57: 1181-1189
        • Varma N.
        Rationale and design of a prospective study of the efficacy of a remote monitoring system used in implantable cardioverter defibrillator follow-up: the Lumos-T Reduces Routine Office Device Follow-Up Study (TRUST) study.
        Am Heart J. 2007; 154: 1029-1034
        • Guedon-Moreau L.
        • Lacroix D.
        • Sadoul N.
        • Clementy J.
        • Kouakam C.
        • Hermida J.S.
        • Aliot E.
        • Boursier M.
        • Bizeau O.
        • Kacet S.
        A randomized study of remote follow-up of implantable cardioverter defibrillators: safety and efficacy report of the ECOST trial.
        Eur Heart J. 2012; 34: 605-614
        • Lazarus A.
        Remote, wireless, ambulatory monitoring of implantable pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy systems: analysis of a worldwide database.
        Pacing Clin Electrophysiol. 2007; 30: S2-S12
        • Mabo P.
        • Victor F.
        • Bazin P.
        • Ahres S.
        • Babuty D.
        • Da Costa A.
        • Binet D.
        • Daubert J.C.
        COMPAS Trial Investigators. A randomized trial of long-term remote monitoring of pacemaker recipients (the COMPAS trial).
        Eur Heart J. 2012; 33: 1105-1111
        • Varma N.
        • Michalski J.
        • Epstein A.E.
        • Schweikert R.
        Automatic remote monitoring of implantable cardioverter-defibrillator lead and generator performance: the Lumos-T Safely RedUceS RouTine Office Device Follow-up (TRUST) Trial.
        Circ Arrhythm Electrophysiol. 2010; 3: 428-436
        • Landolina M.
        • Perego G.B.
        • Lunati M.
        • Curnis A.
        • Guenzati G.
        • Vicentini A.
        • Parati G.
        • Borghi G.
        • Zanaboni P.
        • Valsecchi S.
        • Marzegalli M.
        Remote monitoring reduces healthcare use and improves quality of care in heart failure patients with implantable defibrillators: the evolution of management strategies of heart failure patients with implantable defibrillators (EVOLVO) study.
        Circulation. 2012; 125: 2985-2992
        • Calò L.
        • Gargaro A.
        • De Ruvo E.
        • Palozzi G.
        • Sciarra L.
        • Rebecchi M.
        • Guarracini F.
        • Fagagnini A.
        • Piroli E.
        • Lioy E.
        • Chirico A.
        Economic impact of remote monitoring on ordinary follow-up of implantable cardioverter defibrillators as compared with conventional in-hospital visits: a single-center prospective and randomized study.
        J Interv Card Electrophysiol. 2013; 37: 69-78
        • Hindricks G.
        • Taborsky M.
        • Glikson M.
        • et al.
        Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial.
        Lancet. 2014; 384: 583-590
        • Saxon L.A.
        • Hayes D.L.
        • Gilliam F.R.
        • Heidenreich P.A.
        • Day J.
        • Seth M.
        • Meyer T.E.
        • Jones P.W.
        • Boehmer J.P.
        Long-term outcome after ICD and CRT implantation and influence of remote device follow-up: the ALTITUDE survival study.
        Circulation. 2010; 122: 2359-2367
      1. Varma NPJ, Snell J, Fischer A, Dalal N, Mittal S. The relationship between level of adherence to automatic wireless remote monitoring and survival in pacemaker and defibrillator patients. J Am Coll Cardiol. In press. Available at: http://dx.doi.org/10.1016/j.jacc.2015.04.033

        • Fauchier L.
        • Sadoul N.
        • Kouakam C.
        • Briand F.
        • Chauvin M.
        • Babuty D.
        • Clementy J.
        Potential cost savings by telemedicine-assisted long-term care of implantable cardioverter defibrillator recipients.
        Pacing Clin Electrophysiol. 2005; 28: S255-S259
        • Raatikainen M.J.
        • Uusimaa P.
        • van Ginneken M.M.
        • Janssen J.P.
        • Linnaluoto M.
        Remote monitoring of implantable cardioverter defibrillator patients: a safe, time-saving, and cost-effective means for follow-up.
        Europace. 2008; 10: 1145-1151
        • Marzegalli M.
        • Lunati M.
        • Landolina M.
        • et al.
        Remote monitoring of CRT-ICD: the multicenter Italian CareLink evaluation—ease of use, acceptance, and organizational implications.
        Pacing Clin Electrophysiol. 2008; 31: 1259-1264
        • Ricci R.P.
        • Morichelli L.
        • Quarta L.
        • Sassi A.
        • Porfili A.
        • Laudadio M.T.
        • Gargaro A.
        • Santini M.
        Long-term patient acceptance of and satisfaction with implanted device remote monitoring.
        Europace. 2010; 12: 674-679
        • Petersen H.H.
        • Larsen M.C.
        • Nielsen O.W.
        • Kensing F.
        • Svendsen J.H.
        Patient satisfaction and suggestions for improvement of remote ICD monitoring.
        J Interv Card Electrophysiol. 2012; 34: 317-324
        • Morichelli L.
        • Porfili A.
        • Quarta L.
        • Sassi A.
        • Ricci R.P.
        Implantable cardioverter defibrillator remote monitoring is well accepted and easy to use during long-term follow-up.
        J Interv Card Electrophysiol. 2014; 41: 203-209
        • Guédon-Moreau L.
        • Lacroix D.
        • Sadoul N.
        • Clémenty J.
        • Kouakam C.
        • Hermida J.S.
        • Aliot E.
        • Kacet S.
        ECOST Investigators. Costs of remote monitoring vs. ambulatory follow-ups of implanted cardioverter defibrillators in the randomized ECOST study.
        Europace. 2014; 16: 1181-1188
        • Zanaboni P.
        • Landolina M.
        • Marzegalli M.
        • Lunati M.
        • Perego G.B.
        • Guenzati G.
        • Curnis A.
        • Valsecchi S.
        • Borghetti F.
        • Borghi G.
        • Masella C.
        Cost-utility analysis of the EVOLVO study on remote monitoring for heart failure patients with implantable defibrillators: randomized controlled trial.
        J Med Internet. 2013; 15: e106
        • Burri H.
        • Sticherling C.
        • Wright D.
        • Makino K.
        • Smala A.
        • Tilden D.
        Cost-consequence analysis of daily continuous remote monitoring of implantable cardiac defibrillator and resynchronization devices in the UK.
        Europace. 2013; 15: 1601-1608
        • Ricci R.P.
        • Vicentini A.
        • D’Onofrio A.
        • et al.
        Impact of in-clinic follow-up visits in patients with implantable cardioverter defibrillators: demographic and socioeconomic analysis of the TARIFF study population.
        J Interv Card Electrophysiol. 2013; 38: 101-106
        • de Asmundis C.
        • Ricciardi D.
        • Namdar M.
        • Chierchia G.-B.
        • Sarkozy A.
        • Brugada P.
        Role of home monitoring in children with implantable cardioverter defibrillators for Brugada syndrome.
        Europace. 2013; 15: i17-i25
        • Neuzil P.
        • Taborsky M.
        • Holy F.
        • Wallbrueck K.
        Early automatic remote detection of combined lead insulation defect and ICD damage.
        Europace. 2008; 10: 556-557
        • Varma N.
        Remote monitoring for advisories: automatic early detection of silent lead failure.
        Pacing Clin Electrophysiol. 2009; 32: 525-527
        • Spencker S.
        • Coban N.
        • Koch L.
        • Schirdewan A.
        • Muller D.
        Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failure.
        Europace. 2009; 11: 483-488
        • Guedon-Moreau L.
        • Kouakam C.
        • Klug D.
        • MarquiÉ C.
        • Brigadeau F.
        • BoulÉ S.
        • Blangy H.
        • Lacroix D.
        • ClÉMenty J.
        • Sadoul N.
        • Kacet S.
        on behalf of the EtI. Decreased delivery of inappropriate shocks achieved by remote monitoring of ICD: a substudy of the ECOST trial.
        J Cardiovasc Electrophysiol. 2014; 25: 763-770
        • Ricci R.P.
        • Pignalberi C.
        • Landolina M.
        • et al.
        Ventricular rate monitoring as a tool to predict and prevent atrial fibrillation-related inappropriate shocks in heart failure patients treated with cardiac resynchronisation therapy defibrillators.
        Heart. 2014; 100: 848-854
        • Ricci R.P.
        • Morichelli L.
        • Quarta L.
        • Porfili A.
        • Magris B.
        • Giovene L.
        • Torcinaro S.
        • Gargaro A.
        Effect of daily remote monitoring on pacemaker longevity: a retrospective analysis.
        Heart Rhythm. 2015; 12: 330-337
      2. Medtronic. Clinician Manual Supplement ProtectaTM XT/ProtectaTM Projected service life information related to remote monitoring. EVERA™ XT VR DVBB1D1. Manual No: M945739A001A.

        • Varma N.
        • Johnson M.A.
        Prevalence of cancelled shock therapy and relationship to shock delivery in recipients of implantable cardioverter-defibrillators assessed by remote monitoring.
        Pacing Clin Electrophysiol. 2009; 32: S42-S46
        • Ricci R.P.
        • Morichelli L.
        • Santini M.
        Remote control of implanted devices through Home Monitoring technology improves detection and clinical management of atrial fibrillation.
        Europace. 2009; 11: 54-61
        • Ricci R.P.
        • Morichelli L.
        • D’Onofrio A.
        • Calo L.
        • Vaccari D.
        • Zanotto G.
        • Curnis A.
        • Buja G.
        • Rovai N.
        • Gargaro A.
        Effectiveness of remote monitoring of CIEDs in detection and treatment of clinical and device-related cardiovascular events in daily practice: the HomeGuide Registry.
        Europace. 2013; 15: 970-977
        • Orlov M.V.
        • Ghali J.K.
        • Araghi-Niknam M.
        • Sherfesee L.
        • Sahr D.
        • Hettrick D.A.
        Atrial High Rate Trial Investigators. Asymptomatic atrial fibrillation in pacemaker recipients: incidence, progression, and determinants based on the atrial high rate trial.
        Pacing Clin Electrophysiol. 2007; 30: 404-411
        • Cheung J.W.
        • Keating R.J.
        • Stein K.M.
        • Markowitz S.M.
        • Iwai S.
        • Shah B.K.
        • Lerman B.B.
        • Mittal S.
        Newly detected atrial fibrillation following dual chamber pacemaker implantation.
        J Cardiovasc Electrophysiol. 2006; 17: 1323-1328
        • Bunch T.J.
        • Day J.D.
        • Olshansky B.
        • Stolen K.Q.
        • Mullin C.M.
        INTRINSIC RV Study Investigators. Newly detected atrial fibrillation in patients with an implantable cardioverter-defibrillator is a strong risk marker of increased mortality.
        Heart Rhythm. 2009; 6: 2-8
        • Botto G.L.
        • Padeletti L.
        • Santini M.
        • et al.
        Presence and duration of atrial fibrillation detected by continuous monitoring: crucial implications for the risk of thromboembolic events.
        J Cardiovasc Electrophysiol. 2009; 20: 241-248
        • Glotzer T.V.
        • Hellkamp A.S.
        • Zimmerman J.
        • et al.
        Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke: report of the atrial diagnostics ancillary study of the MOde Selection Trial (MOST).
        Circulation. 2003; 107: 1614-1619
        • Capucci A.
        • Santini M.
        • Padeletti L.
        • et al.
        Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers.
        J Am Coll Cardiol. 2005; 46: 1913-1920
        • Glotzer T.V.
        • Daoud E.G.
        • Wyse D.G.
        • Singer D.E.
        • Ezekowitz M.D.
        • Hilker C.
        • Miller C.
        • Qi D.
        • Ziegler P.D.
        The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study.
        Circ Arrhythm Electrophysiol. 2009; 2: 474-480
        • Shanmugam N.
        • Boerdlein A.
        • Proff J.
        • Ong P.
        • Valencia O.
        • Maier S.K.
        • Bauer W.R.
        • Paul V.
        • Sack S.
        Detection of atrial high-rate events by continuous home monitoring: clinical significance in the heart failure-cardiac resynchronization therapy population.
        Europace. 2012; 14: 230-237
        • Healey J.S.
        • Connolly S.J.
        • Gold M.R.
        • et al.
        Subclinical atrial fibrillation and the risk of stroke.
        N Engl J Med. 2012; 366: 120-129
        • Brambatti M.
        • Connolly S.J.
        • Gold M.R.
        • et al.
        Temporal relationship between subclinical atrial fibrillation and embolic events.
        Circulation. 2014; 129: 2094-2099
      3. Martin DT, Bersohn MM, Waldo AL, Wathen MS, Choucair WK, Lip GYH, Ip J, Holcomb R, Akar JG, Halperin JL, on behalf of the IMPACT Investigators. Randomized trial of atrial arrhythmia monitoring to guide anticoagulation in patients with implanted defibrillator and cardiac resynchronization devices. Eur Heart J. In press. Available at: http://eurheartj.oxfordjournals.org/content/ehj/early/2015/04/22/eurheartj.ehv115.full.pdf

        • January C.T.
        • Wann L.S.
        • Alpert J.S.
        • et al.
        2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.
        J Am Coll Cardiol. 2014; 64: 2246-2280
        • Vollmann D.
        • Nägele H.
        • Schauerte P.
        • Wiegand U.
        • Butter C.
        • Zanotto G.
        • Quesada A.
        • Guthmann A.
        • Hill M.R.
        • Lamp B.
        EISOS Investigators. Clinical utility of intrathoracic impedance monitoring to alert patients with an implanted device of deteriorating chronic heart failure.
        Eur Heart J. 2007; 28: 1835-1840
        • Conraads V.M.
        • Tavazzi L.
        • Santini M.
        • Oliva F.
        • Gerritse B.
        • Yu C.M.
        • Cowie M.R.
        Sensitivity and positive predictive value of implantable intrathoracic impedance monitoring as a predictor of heart failure hospitalizations: the SENSE-HF trial.
        Eur Heart J. 2011; 32: 2266-2273
        • Perego G.B.
        • Landolina M.
        • Vergara G.
        • et al.
        Implantable CRT device diagnostics identify patients with increased risk for heart failure hospitalization.
        J Interv Card Electrophysiol. 2008; 23: 235-242
        • Small R.S.
        • Wickemeyer W.
        • Germany R.
        • Hoppe B.
        • Andrulli J.
        • Brady P.A.
        • Labeau M.
        • Koehler J.
        • Sarkar S.
        • Hettrick D.A.
        • Tang W.H.
        Changes in intrathoracic impedance are associated with subsequent risk of hospitalizations for acute decompensated heart failure: clinical utility of implanted device monitoring without a patient alert.
        J Card Fail. 2009; 15: 475-481
        • Whellan D.J.
        • Ousdigian K.T.
        • Al-Khatib S.M.
        • Pu W.
        • Sarkar S.
        • Porter C.B.
        • Pavri B.B.
        • O’Connor C.M.
        Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study.
        J Am Coll Cardiol. 2010; 55: 1803-1810
        • Catanzariti D.
        • Lunati M.
        • Landolina M.
        • et al.
        Monitoring intrathoracic impedance with an implantable defibrillator reduces hospitalizations in patients with heart failure.
        Pacing Clin Electrophysiol. 2009; 32: 363-370
        • Maines M.
        • Catanzariti D.
        • Cemin C.
        • Vaccarini C.
        • Vergara G.
        Usefulness of intrathoracic fluids accumulation monitoring with an implantable biventricular defibrillator in reducing hospitalizations in patients with heart failure: a case-control study.
        J Interv Card Electrophysiol. 2007; 19: 201-207
        • van Veldhuisen D.J.
        • Braunschweig F.
        • Conraads V.
        • et al.
        Intrathoracic impedance monitoring, audible patient alerts, and outcome in patients with heart failure.
        Circulation. 2011; 124: 1719-1726
        • Hindricks G.
        • Taborsky M.
        • Glikson M.
        • et al.
        Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial.
        Lancet. 2014; 384: 583-590
        • Abraham W.T.
        • Adamson P.B.
        • Bourge R.C.
        • et al.
        Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial.
        Lancet. 2011; 377: 658-666
        • Epstein A.E.
        • DiMarco J.P.
        • Ellenbogen K.A.
        • et al.
        2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.
        J Am Coll Cardiol. 2013; 61: e6-e75
        • Gussak I.
        • Brugada P.
        • Brugada J.
        • Antzelevitch C.
        • Osbakken M.
        • Bjerregaard P.
        ECG phenomenon of idiopathic and paradoxical short QT intervals.
        Card Electrophysiol Rev. 2002; 6: 49-53
        • Antzelevitch C.
        • Brugada P.
        • Borggrefe M.
        • et al.
        Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association.
        Circulation. 2005; 111: 659-670
        • de Asmundis C.
        • Ricciardi D.
        • Namdar M.
        • Chierchia G.B.
        • Sarkozy A.
        • Brugada P.
        Role of home monitoring in children with implantable cardioverter defibrillators for Brugada syndrome.
        Europace. 2013; 15: i17-i25
        • Schwartz P.J.
        • Spazzolini C.
        • Priori S.G.
        • et al.
        Who are the long-QT syndrome patients who receive an implantable cardioverter-defibrillator and what happens to them? Data from the European Long-QT Syndrome Implantable Cardioverter-Defibrillator (LQTS ICD) Registry.
        Circulation. 2010; 122: 1272-1282
        • Berul C.I.
        • Van Hare G.F.
        • Kertesz N.J.
        • Dubin A.M.
        • Cecchin F.
        • Collins K.K.
        • Cannon B.C.
        • Alexander M.E.
        • Triedman J.K.
        • Walsh E.P.
        • Friedman R.A.
        Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients.
        J Am Coll Cardiol. 2008; 51: 1685-1691
        • Maron B.J.
        • Spirito P.
        • Shen W.K.
        • et al.
        Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.
        JAMA. 2007; 298: 405-412
        • Sacher F.
        • Probst V.
        • Bessouet M.
        • et al.
        Remote implantable cardioverter defibrillator monitoring in a Brugada syndrome population.
        Europace. 2009; 11: 489-494
        • Hayes D.L.
        • Boehmer J.P.
        • Day J.D.
        • Gilliam III, F.R.
        • Heidenreich P.A.
        • Seth M.
        • Jones P.W.
        • Saxon L.A.
        Cardiac resynchronization therapy and the relationship of percent biventricular pacing to symptoms and survival.
        Heart Rhythm. 2011; 8: 1469-1475
        • Gilliam F.R.
        • Hayes D.L.
        • Boehmer J.P.
        • Day J.
        • Heidenreich P.A.
        • Seth M.
        • Jones P.W.
        • Stein K.M.
        • Saxon L.A.
        Real world evaluation of dual-zone ICD and CRT-D programming compared to single-zone programming: the ALTITUDE REDUCES study.
        J Cardiovasc Electrophysiol. 2011; 22: 1023-1029
      4. Heart Rhythm Society. Resource—Specifications for HRS-developed Measures. 2015.A HRS-developed physician-level performance measure “In-Person Evaluation Following Implantation of a Cardiovascular Implantable Electronic Device (CIED)” is available as a tool to measure adherence to in-person follow-up. www.hrsonline.org/hrs/Practice-Guidance/Quality-Outcomes-Reporting/Physician-Quality-Reporting-Systems-PQRS/Resource-Specifications-for-HRS-Measures. Accessed April 8, 2015.

        • Winters S.L.
        • Kusumoto F.M.
        • Miller J.M.
        • Slotwiner D.J.
        The role of the Heart Rhythm Society in integrating the healthcare enterprise.
        Heart Rhythm. 2007; 4: 122-124
      5. IEEE. 11073-10103-2012—Health informatics--Point-of-care medical device communication Part 10103: Nomenclature--Implantable device, cardiac. http://standards.ieee.org/findstds/standard/11073-10103-2012.html. Accessed April 8, 2015.

      6. Integrating the Healthcare Enterprise. Patient Care Device Technical Framework. 2014. http://www.ihe.net/Technical_Frameworks/#pcd. Accessed April 8, 2015.

        • Heidbuchel H.
        • Hindricks G.
        • Broadhurst P.
        • et al.
        EuroEco (European Health Economic Trial on Home Monitoring in ICD Patients): a provider perspective in five European countries on costs and net financial impact of follow-up with or without remote monitoring.
        Eur Heart J. 2015; 36: 158-169
      7. Amy Dockser Marcus CW. Heart gadgets test privacy—law limits. Wall St J. Available at: http://www.wsj.com/articles/SB10001424052970203937004578078820874744076

        • Halperin D.
        • Heydt-Benjamin T.S.
        • Ransford B.
        • Clark S.S.
        • Defen B.
        • Morgan W.
        • Fu K.
        • Kohno T.
        • Maisel W.H.
        Pacemakers and implantable cardiac defibrillators: software radio attacks and zero-power defenses. security and privacy.
        Proceedings of the IEEE Symposium on Security and Privacy. 2008; : 129-142
        • Sanna T.
        • Diener H-C
        • Passman R.S.
        • Di Lazzaro V.
        • Bernstein R.A.
        • Morillo C.A.
        • et al.
        Cryptogenic stroke and underlying atrial fibrillation.
        New England Journal of Medicine. 2014; 370: 2478-2486